Pancreatic Cancer Research

ResearcherUniversity of CincinnatiActive in the last 2 years

Kevin M. Turner

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1962-5065; OpenAlex author ID A5014798513. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2022: 5 papers · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers

Papers 9

  1. Large language models as clinical decision support tools: A call for careful implementation in the care of patients with pancreatic cancer. Co-author DOI 10.1016/j.surg.2025.109378↗
  2. Pancreatic Ductal Adenocarcinoma Among Octogenarians: A Case for Multimodal Therapy with Appropriate Selection to Optimize Outcomes. Co-author DOI 10.1245/s10434-025-17249-1↗
  3. Pancreatic Cancer Screening among High-risk Individuals. Co-author DOI 10.1016/j.suc.2024.03.002↗
  4. Acid sphingomyelinase expression is associated with survival in resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00109-023-02331-6↗
  5. Radiation therapy in borderline resectable pancreatic cancer: A review. Co-author DOI 10.1016/j.surg.2021.12.013↗
  6. Systemic Therapy for Resected Pancreatic Adenocarcinoma: How Much is Enough? Co-author DOI 10.1245/s10434-022-11363-0↗
  7. ASO Author Reflections: An Underappreciated Metric: Systemic Chemotherapy Dose Density in Pancreatic Cancer. Co-author DOI 10.1245/s10434-022-11390-x↗
  8. Is There a Benefit to Adjuvant Chemotherapy in Resected, Early Stage Pancreatic Ductal Adenocarcinoma? Co-author DOI 10.1245/s10434-022-11580-7↗
  9. ASO Author Reflections: The Survival Advantage Persists: Benefit of Adjuvant Chemotherapy in Resected, Stage IA Pancreatic Cancer. Co-author DOI 10.1245/s10434-022-11650-w↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sameer H. Patel · 8 shared papers, 2022–2025 · strength 2.27
  2. Syed Ameen Ahmad · 4 shared papers, 2022–2025 · strength 0.98
  3. Gregory C. Wilson · 4 shared papers, 2022–2023 · strength 0.62
  4. Davendra P. S. Sohal · 3 shared papers, 2022 · strength 0.44
  5. Jordan R. Kharofa · 3 shared papers, 2022 · strength 0.44
  6. Olugbenga Olanrele Olowokure · 3 shared papers, 2022 · strength 0.44
  7. Erich Gulbins · 1 shared paper, 2023 · strength 0.18
  8. Syed Arif Ahmad · 1 shared paper, 2023 · strength 0.18
  9. Ildikò Szabó · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.